ModivCare Ebit from 2010 to 2025

MODV Stock  USD 4.32  0.08  1.89%   
ModivCare EBIT yearly trend continues to be fairly stable with very little volatility. EBIT is likely to outpace its year average in 2025. During the period from 2010 to 2025, ModivCare EBIT regression line of quarterly data had mean square error of 4643.3 T and geometric mean of  38,949,537. View All Fundamentals
 
EBIT  
First Reported
2000-09-30
Previous Quarter
-100.9 M
Current Value
-6.5 M
Quarterly Volatility
15.7 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ModivCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ModivCare's main balance sheet or income statement drivers, such as Interest Expense of 83.5 M, Selling General Administrative of 260.4 M or Total Revenue of 3.3 B, as well as many indicators such as Price To Sales Ratio of 0.25, Dividend Yield of 0.0527 or PTB Ratio of 4.36. ModivCare financial statements analysis is a perfect complement when working with ModivCare Valuation or Volatility modules.
  
Check out the analysis of ModivCare Correlation against competitors.
For more information on how to buy ModivCare Stock please use our How to Invest in ModivCare guide.

Latest ModivCare's Ebit Growth Pattern

Below is the plot of the Ebit of ModivCare over the last few years. It is ModivCare's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ModivCare's overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
       Timeline  

ModivCare Ebit Regression Statistics

Arithmetic Mean5,965,419
Geometric Mean38,949,537
Coefficient Of Variation1,285
Mean Deviation55,285,895
Median32,293,000
Standard Deviation76,672,890
Sample Variance5878.7T
Range259.5M
R-Value(0.51)
Mean Square Error4643.3T
R-Squared0.26
Significance0.04
Slope(8,256,018)
Total Sum of Squares88181T

ModivCare Ebit History

2025-139.4 M
2024-146.7 M
2023-127.6 M
202245.4 M
202178.4 M
2020112.8 M
2019-4.7 M

Other Fundumenentals of ModivCare

About ModivCare Financial Statements

ModivCare investors use historical fundamental indicators, such as ModivCare's Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in ModivCare. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBIT-146.7 M-139.4 M
EBITDA-26.8 M-25.5 M
Ebt Per Ebit 1.72  1.61 
Ebit Per Revenue(0.06)(0.06)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ModivCare Stock Analysis

When running ModivCare's price analysis, check to measure ModivCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ModivCare is operating at the current time. Most of ModivCare's value examination focuses on studying past and present price action to predict the probability of ModivCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ModivCare's price. Additionally, you may evaluate how the addition of ModivCare to your portfolios can decrease your overall portfolio volatility.